ONO PHARMA USA Announces 2025 Golden Ticket CompetitionNow Accepting Applications from Innovative Startups

ONO PHARMA USA Announces 2025 Golden Ticket CompetitionNow Accepting Applications from Innovative Startups

Ono Partnering with LabCentral and MBC BioLabs for Fifth Consecutive Year CAMBRIDGE, Mass., April 27, 2025 /PRNewswire/ -- ONO PHARMA USA today announced partnerships with LabCentral in Cambridge, Mass., and MBC BioLabs in San Francisco and San...

OneConnect Releases ESG Report for the Third Consecutive Year, Strengthening Its Leadership in Sustainable Finance

OneConnect Releases ESG Report for the Third Consecutive Year, Strengthening Its Leadership in Sustainable Finance

SHANGHAI, April 25, 2025 /PRNewswire/ -- On April 24, OneConnect Financial Technology Co., Ltd ("OneConnect" or the "Company", NYSE: OCFT, HKSE: 6638) officially released its 2024 Environmental, Social, and Governance (ESG) Report. This marks the...

Meihua International Medical Technologies Co., Ltd. Reports 2024 Financial Year Results

Meihua International Medical Technologies Co., Ltd. Reports 2024 Financial Year Results

YANGZHOU, China, April 25, 2025 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating...

2025 Belt and Road Creativity and Sustainable Development Seminar Held in Beijing

2025 Belt and Road Creativity and Sustainable Development Seminar Held in Beijing

BEIJING, April 25, 2025 /PRNewswire/ -- A news report from CRI Online: Group photo of officials and staff members On April 20, the 2025 Belt and Road Creativity and Sustainable Development Seminar was held in Beijing. It was co-hosted by the...

TCL Solar Debuts in Korean Market, Pioneering a New Era of Renewable Energy Innovation

TCL Solar Debuts in Korean Market, Pioneering a New Era of Renewable Energy Innovation

DAEGU, South Korea, April 24, 2025 /PRNewswire/ -- Pioneering New Asia Solar Partnerships, TCL Solar debuted its cutting-edge solar technologies at Korea International Green Energy Expo, the nation's premier renewable energy event held at Daegu EXCO...

ROHM Develops New High-power-density SiC Power Modules

ROHM Develops New High-power-density SiC Power Modules

- Compact, High-heat-dissipation Design Sets New Standard for OBC - KYOTO, Japan, April 24, 2025 /PRNewswire/ -- ROHM Co., Ltd. has developed new 4-in-1 and 6-in-1 SiC molded modules in the HSDIP20 package for power-factor-correction (PFC) circuits...

Kelun-Biotech to Present Results of Six Clinical Studies at 2025 ASCO Annual Meeting

Kelun-Biotech to Present Results of Six Clinical Studies at 2025 ASCO Annual Meeting

CHENGDU, China, April 24, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) announced that it will present results from six Kelun-led clinical studies at the 2025 American Society of Clinical Oncology (ASCO) Annual...

Canton Fair Connects Global Buyers with Chinese Suppliers for Emerging Trends Like Glamping

Canton Fair Connects Global Buyers with Chinese Suppliers for Emerging Trends Like Glamping

GUANGZHOU, China, April 24, 2025 /PRNewswire/ -- At its 137th session, China Import and Export Fair (Canton Fair) continues to demonstrate its capacity to respond swiftly to evolving global consumer trends. With its broad product range and competent...

2025 Medtec Free Pre-Registration Kicks Off! Meet Over 1000 Chinese Local Enterprises

2025 Medtec Free Pre-Registration Kicks Off! Meet Over 1000 Chinese Local Enterprises

SHANGHAI, April 24, 2025 /PRNewswire/ -- The 2025 Medtec International Medical Device Design & Manufacturing Technology Exhibition (hereinafter referred to as 2025 Medtec) will be held at the Halls 1&2 of Shanghai World Expo Exhibition &...

Doer Biologics Announces First Patient Dosed in Phase 2 Study of DR10624 for Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

Doer Biologics Announces First Patient Dosed in Phase 2 Study of DR10624 for Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

HANGZHOU, China, April 22, 2025 /PRNewswire/ -- Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announces that DR10624, its...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 46
  • menu
    menu